Admission Date:  [**2189-6-16**]              Discharge Date:   [**2189-6-20**]  Date of Birth:  [**2126-1-3**]             Sex:   F  Service: NEUROLOGY  Allergies: No Known Allergies / Adverse Drug Reactions  Attending:[**First Name3 (LF) 5018**] Chief Complaint: not speaking, R sided weakness  Major Surgical or Invasive Procedure: TPA administration TEE   History of Present Illness: Neurology at bedside for evaluation after code stroke activation within: 1 minutes Time (and date) the patient was last known well: 19:45 (24h clock) NIH Stroke Scale Score: 23 t-[**MD Number(3) 6360**]:  Yes Time t-PA was given 21:11 (24h clock)  I was present during the CT scanning and reviewed the images instantly within 20 minutes of their completion.
Past Medical History: Prior stroke 20 yrs ago HTN DM   Social History: No smoking, etoh, drugs  Family History: No Sz, early strokes  Physical Exam: Physical Exam on Admission: Vitals: T: 98  P:80  R: 16  BP:153/80  SaO2:100 General: Awake NAD.
Sensory: 1 9.
Language: 3 10.
Dysarthria: 2 11.
Pertinent Results: [**2189-6-16**] 08:40PM   CREAT-1.0 [**2189-6-16**] 08:40PM   estGFR-Using this [**2189-6-16**] 08:38PM   UREA N-27* [**2189-6-16**] 08:38PM   GLUCOSE-191* NA+-143 K+-4.3 CL--102 TCO2-24 [**2189-6-16**] 08:38PM   WBC-10.1 RBC-5.72* HGB-12.2 HCT-39.8 MCV-70* MCH-21.3* MCHC-30.6* RDW-15.9* [**2189-6-16**] 08:38PM   PLT COUNT-256 [**2189-6-16**] 08:38PM   PT-10.6 PTT-33.1 INR(PT)-1.0  [**2189-6-17**] 04:56AM BLOOD %HbA1c-6.7* eAG-146* [**2189-6-17**] 04:56AM BLOOD Triglyc-123 HDL-46 CHOL/HD-3.6 LDLcalc-95  CT/A/P: Plain CT negative for acute process.
MRI brain [**2189-6-17**]: IMPRESSION: 1.
No atrial septal defect or patent foramen ovale is seen by 2D, color Doppler or saline contrast with maneuvers.
The estimated right atrial pressure is 0-5 mmHg.
Neuro: BP was closely controlled with goal SBP < 180.
By the morning of [**6-17**] her exam had markedly improved and she was essentially back to baseline except for mild R NLF flattening.
MRI showed two small infarcts in the left frontal and parietal lobes.
Lipid panel was significant for LDL of 95, HbA1c was 6.7%.
BP was closely monitored as above.
TTE showed no abnormalities.
Hct on [**6-17**] had decreased a bit from 39.8 -> 35.2, likely at least partially dilutional.
PENDING RESULTS: None  TRANSITIONAL CARE ISSUES: Patient will need to be maintained on pradaxa and get her PTT checked in the future to ensure it is effective.
Please take pradaxa twice a day to prevent blood clots 2.
